January 24, 2023, Quest Diagnostics Incorporated (NYSE: DGX) trading session started at the price of $145.85, that was -2.12% drop from the session before. During the day, the shares moved up to $146.61 and dropped to $143.575 before settling in for the closing price of $147.01. A 52-week range for DGX has been $120.40 – $158.34.
Will You Miss Out On This Growth Stock Boom?
A new megatrend in the fintech market is well underway. Mobile payments are projected to boom into a massive $12 trillion market by 2028. According to Motley Fool this growth stock could "deliver huge returns." Not only in the immediate future but also over the next decade. Especially since the man behind this company is a serial entrepreneur who has been wildly successful over the years.
And this is just one of our 5 Best Growth Stocks To Own For 2023.
During the last 5-year period, the sales growth of Healthcare Sector giant was 7.50%. When this article was written, the company’s average yearly earnings per share was at 48.20%. With a float of $113.07 million, this company’s outstanding shares have now reached $116.00 million.
Let’s determine the extent of company efficiency that accounts for 40000 employees.
Quest Diagnostics Incorporated (DGX) Insider Activity
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Quest Diagnostics Incorporated stocks. The insider ownership of Quest Diagnostics Incorporated is 0.20%, while institutional ownership is 95.00%. The most recent insider transaction that took place on Dec 01, was worth 308,812. In this transaction Director of this company sold 2,025 shares at a rate of $152.50, taking the stock ownership to the 24,149 shares. Before that another transaction happened on Nov 28, when Company’s SVP, Regional Businesses sold 40,765 for $149.18, making the entire transaction worth $6,081,262. This insider now owns 67,733 shares in total.
Quest Diagnostics Incorporated (DGX) Earnings and Forecasts
Going through the last 3-months fiscal report unveiled on the 9/29/2022, it has been observed that the corporation posted $2.36 earnings per share (EPS) during the time that was better than consensus figure (set at $2.19) by $0.17. Wall Street market experts anticipate that the next fiscal year will bring earnings of 2.09 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 48.20% per share during the next fiscal year.
Quest Diagnostics Incorporated (NYSE: DGX) Trading Performance Indicators
You can see what Quest Diagnostics Incorporated (DGX) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 1.30. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.59. Likewise, its price to free cash flow for the trailing twelve months is 14.15.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 10.15, a number that is poised to hit 1.90 in the next quarter and is forecasted to reach 8.60 in one year’s time.
Technical Analysis of Quest Diagnostics Incorporated (DGX)
Looking closely at Quest Diagnostics Incorporated (NYSE: DGX), its last 5-days average volume was 0.94 million, which is a drop from its year-to-date volume of 1.1 million. As of the previous 9 days, the stock’s Stochastic %D was 13.67%. Additionally, its Average True Range was 2.84.
During the past 100 days, Quest Diagnostics Incorporated’s (DGX) raw stochastic average was set at 61.95%, which indicates a significant increase from 2.36% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 17.80% in the past 14 days, which was lower than the 23.13% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $150.54, while its 200-day Moving Average is $138.20. However, in the short run, Quest Diagnostics Incorporated’s stock first resistance to watch stands at $145.82. Second resistance stands at $147.73. The third major resistance level sits at $148.85. If the price goes on to break the first support level at $142.78, it is likely to go to the next support level at $141.66. Should the price break the second support level, the third support level stands at $139.74.
Quest Diagnostics Incorporated (NYSE: DGX) Key Stats
There are 113,887K outstanding shares of the company, which has a market capitalization of 16.37 billion. As of now, sales total 10,788 M while income totals 1,995 M. Its latest quarter income was 2,486 M while its last quarter net income were 256,000 K.